Dec 16, 2025
Lennar Q4 Earnings: Revenue Beat, EPS Miss, Shares Slip

Lennar Corp (NYSE:LEN) reported financial results for the fourth quarter after the market close on Tuesday. Here’s a rundown of the homebuilder’s report. Lennar stock is showing notable weakness. Why is LEN stock dropping? Q4 Highlights: Lennar reported fourth-quarter revenue of…

Dec 16, 2025
Linde Shares Hit Intraday High After Key Signal

Linde PLC (NASDAQ:LIN) experienced a significant Power Inflow alert, a key bullish indicator that is closely tracked by traders who value order flow analytics, specifically institutional and retail order flow data. At 10:04 AM EST on December 16, LIN triggered…

Dec 16, 2025
Oil Falls To $55 And Energy Stocks Suffer Worst Day Since April

Oil and gas stocks extended their selloff Tuesday as crude prices slid to levels not seen in nearly five years, pressured by rising expectations of a Russia-Ukraine peace deal and mounting supply concerns. West Texas Intermediate crude – as tracked…

Dec 16, 2025
Trading PayPal Stock? Here’s What You Need To Know

PayPal Holdings Inc (NASDAQ:PYPL) shares are moving higher Tuesday after the company announced plans to establish a bank, which could enhance its ability to provide business lending solutions. PayPal Holdings stock is gaining positive traction. What’s pushing PYPL stock higher? What…

Dec 16, 2025
Robotics ETFs Or EV ETFs: The Safer Bet For 2026?

Thematic investors are split between two big future bets: robotics and electric vehicles. But for now, each has a different engine driving it. Robotics is gaining traction with politicians in Washington. Meanwhile, priority attention is still focused on car sales…

Dec 16, 2025
Is Tilray Stock Headed To New Highs? What You Need To Know

Tilray Brands Inc (NASDAQ:TLRY) shares are in the spotlight Tuesday, surging over 20% amid continued chatter about potential marijuana reclassification. Tilray Brands stock is showing exceptional strength. What’s behind TLRY gains? What To Know: The move in Tilray shares appears to…

Dec 16, 2025
Why Is Monte Rosa Stock Trading Higher Today?

Monte Rosa Therapeutics Inc. (NASDAQ:GLUE) shared interim data from an ongoing Phase 1/2 clinical study evaluating MRT-2359 in combination with enzalutamide in heavily pretreated patients with metastatic castration-resistant prostate cancer (mCRPC). The Phase 1/2 study evaluated 0.5 mg and 0.75…